tiprankstipranks
Advertisement
Advertisement

VRTX Stock Latest News

Vertex Pharmaceuticals: Solid CF Franchise and Emerging Pipeline Support Buy Rating and Premium Valuation
RatingsVertex Pharmaceuticals: Solid CF Franchise and Emerging Pipeline Support Buy Rating and Premium Valuation
10h ago
VRTX
Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley
5d ago
VRTX
Vertex Pharmaceuticals price target raised to $543 from $541 at RBC Capital
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $543 from $541 at RBC Capital
8d ago
VRTX
Halozyme enters global global collaboration and license agreement with Vertex
PremiumThe Fly
Halozyme enters global global collaboration and license agreement with Vertex
8d ago
HALO
VRTX
Anthropic Finalizes $400 Million Takeover of AI Startup Coefficient Bio
PremiumMarket News
Anthropic Finalizes $400 Million Takeover of AI Startup Coefficient Bio
12d ago
NVO
SNY
Vertex announces U.S. FDA approval for label extensions of Alyftrek, Trikafta
PremiumThe FlyVertex announces U.S. FDA approval for label extensions of Alyftrek, Trikafta
14d ago
VRTX
Vertex Advances FDA Filing for IgA Nephropathy Therapy
Premium
Company Announcements
Vertex Advances FDA Filing for IgA Nephropathy Therapy
15d ago
8K
VRTX
Vertex’s VX-407 Contraceptive Interaction Study Reaches Completion: What Investors Should Watch
Premium
Company Announcements
Vertex’s VX-407 Contraceptive Interaction Study Reaches Completion: What Investors Should Watch
16d ago
VRTX
Vertex Pharmaceuticals: Resilient CF Franchise and Advancing Pipeline Support Buy Rating Despite Label Headwinds
PremiumRatings
Vertex Pharmaceuticals: Resilient CF Franchise and Advancing Pipeline Support Buy Rating Despite Label Headwinds
16d ago
VRTX
Vertex’s VX-407 Kidney Study Completion: What Phase 1 Progress Means For VRTX Investors
PremiumCompany Announcements
Vertex’s VX-407 Kidney Study Completion: What Phase 1 Progress Means For VRTX Investors
19d ago
VRTX
Maze Therapeutics share sell-off an ‘overreaction,’ says Raymond James
PremiumThe Fly
Maze Therapeutics share sell-off an ‘overreaction,’ says Raymond James
21d ago
MAZE
VRTX
Leerink remains bullish on Maze, says Vertex comparison ‘apples to oranges’
PremiumThe Fly
Leerink remains bullish on Maze, says Vertex comparison ‘apples to oranges’
21d ago
MAZE
VRTX
TTD, OCGN, STZ, VRTX, LCID Trending With Analysts
PremiumWeekend UpdatesTTD, OCGN, STZ, VRTX, LCID Trending With Analysts
26d ago
STZ
TTD
3 Best Healthcare Stocks to Buy in March 2026, According to Analysts
Premium
Market News
3 Best Healthcare Stocks to Buy in March 2026, According to Analysts
26d ago
LLY
UNH
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
Premium
The Fly
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
27d ago
AMGN
REGN
Amgen price target raised to $390 from $375 at Wells Fargo
PremiumThe Fly
Amgen price target raised to $390 from $375 at Wells Fargo
27d ago
AMGN
REGN
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
28d ago
CF
EXR
Maxim upgrades Vertex to Buy on diversification of revenue
PremiumThe Fly
Maxim upgrades Vertex to Buy on diversification of revenue
28d ago
VRTX
Vertex Pharmaceuticals upgraded to Buy from Hold at Maxim
PremiumThe Fly
Vertex Pharmaceuticals upgraded to Buy from Hold at Maxim
28d ago
VRTX
Insmed assumed with a Buy at Jefferies
PremiumThe FlyInsmed assumed with a Buy at Jefferies
1M ago
INSM
VRTX
3 Best Trending Stocks, According to Analysts – 3/12/2026
Premium
Market News
3 Best Trending Stocks, According to Analysts – 3/12/2026
1M ago
FTNT
ORCL
Vertex Pharmaceuticals price target raised to $525 from $490 at Truist
Premium
The Fly
Vertex Pharmaceuticals price target raised to $525 from $490 at Truist
1M ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >